Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
Merck, known as MSD outside of the United States and Canada, and Kelun-Biotech, a clinical-stage […]
Aldeyra Therapeutics Submits New Drug Application to the U.S. Food and Drug Administration for the Treatment of Primary Vitreoretinal Lymphoma
Aldeyra Therapeutics has announced the submission of a New Drug Application (NDA) to the US […]
Telix Pharmaceuticals ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU Along with Theranostic Pipeline Advances
Telix Pharmaceuticals has announced that the completed pivotal Phase III ZIRCON study of TLX250-CDx in […]
Phio Pharmaceuticals Announces New Clinical Program to Study PH-762 for the Treatment of Cutaneous Squamous Cell Carcinoma
Phio Pharmaceuticals has announced it expects to file an IND in the US in the […]
Moleculin Receives Approval in Italy to Conduct Trial for the Treatment of Acute Myeloid Leukemia
Moleculin Biotech, a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting […]
Biomica Raises $20 Million in a Funding Round to Advance its Pipeline of Microbiome-based Therapeutics
Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene, has […]
Dxcover Secures Grant from the European Innovation Council to Further Develop Platform for Early Cancer Detection Using Infrared Spectroscopy
Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of […]
ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® for the Treatment of Lymphoma
ADC Therapeutics SA and Swedish Orphan Biovitrum AB (Sobi) has announced the European Commission (EC) […]
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Kite and Tmunity Therapeutics have announced that the companies have signed an agreement in which […]
OneOncology Partners Add Practices and Physicians to National Platform
OneOncology, a US national platform for independent oncology practices, announced recent significant practice growth and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more